Serial Observation of Drug-Eluting Absorbable Metal Scaffold
Author(s) -
Ron Waksman,
Francesco Prati,
Nico Bruining,
Michael Haude,
Dirk Böse,
Hironori Kitabata,
Paul Erné,
Stefan Verheye,
Hubertus Degen,
Paul Vermeersch,
Luca Di Vito,
Jacques Koolen,
Raimund Erbel
Publication year - 2013
Publication title -
circulation cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.621
H-Index - 95
eISSN - 1941-7632
pISSN - 1941-7640
DOI - 10.1161/circinterventions.113.000693
Subject(s) - medicine , scaffold , drug , bioresorbable scaffold , percutaneous coronary intervention , surgery , pharmacology , biomedical engineering , myocardial infarction
The drug-eluting absorbable metal scaffold has demonstrated feasibility, safety, and promising clinical and angiographic outcomes at 12 months in human coronary arteries. This study aimed to evaluate the degradation rate and long-term vascular responses to drug-eluting absorbable metal scaffold.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom